| Mr Philip Warren Early, MD | |
|
755 Ne Brookcliff Ln, Bainbridge Island, WA 98110-3965 | |
| (206) 842-3385 | |
| (206) 842-3385 |
| Full Name | Mr Philip Warren Early |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 39 Years |
| Location | 755 Ne Brookcliff Ln, Bainbridge Island, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720030570 | NPI | - | NPPES |
| 00G655610 | Other | CA | BS OF CA |
| 00G655610 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | G65561 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Wa Anesthesia Services, Pc | 9335298884 | 90 |
News Archive
Today's headlines include reports about how the day-after debate about the Congressional Budget Office's updated health law projections played out on Capitol Hill.
Depression is a worldwide problem, with serious consequences for individual health and the economy, and rapid and effective screening tools are thus urgently needed to counteract its increasing prevalence.
High levels of public support for strict measures to control COVID-19 during the first wave of the pandemic did not reflect high levels of public trust in the UK government's honesty, transparency or motives, suggests a new study published in PLOS One.
As the Senate Finance Committee finalizes its health reform proposal, medical-device makers are hoping to convince lawmakers to make one last change, The Wall Street Journal reports. "The Advanced Medical Technology Association, or AdvaMed, the trade group for the larger device manufacturers, wants [Committee Chair Max Baucus of Montana] to reduce $40 billion in fees over the next decade to $15 billion, according to people close to the negotiations. But industry was told that offer is too low.
The US Food and Drug Administration has granted marketing approval to GlaxoSmithKline's new type 2 diabetes drug, branded Tanzeum in the US and Eperzan in Europe, which uses Novozymes' Veltis technology to achieve an extended half-life that means patients are only required to inject their medication once a week.
› Verified 2 days ago
| Entity Name | Grays Harbor Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154378859 PECOS PAC ID: 3577462365 Enrollment ID: O20031231000081 |
News Archive
Today's headlines include reports about how the day-after debate about the Congressional Budget Office's updated health law projections played out on Capitol Hill.
Depression is a worldwide problem, with serious consequences for individual health and the economy, and rapid and effective screening tools are thus urgently needed to counteract its increasing prevalence.
High levels of public support for strict measures to control COVID-19 during the first wave of the pandemic did not reflect high levels of public trust in the UK government's honesty, transparency or motives, suggests a new study published in PLOS One.
As the Senate Finance Committee finalizes its health reform proposal, medical-device makers are hoping to convince lawmakers to make one last change, The Wall Street Journal reports. "The Advanced Medical Technology Association, or AdvaMed, the trade group for the larger device manufacturers, wants [Committee Chair Max Baucus of Montana] to reduce $40 billion in fees over the next decade to $15 billion, according to people close to the negotiations. But industry was told that offer is too low.
The US Food and Drug Administration has granted marketing approval to GlaxoSmithKline's new type 2 diabetes drug, branded Tanzeum in the US and Eperzan in Europe, which uses Novozymes' Veltis technology to achieve an extended half-life that means patients are only required to inject their medication once a week.
› Verified 2 days ago
| Entity Name | Cascade Hernia And Surgical Solutions Ps |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174725402 PECOS PAC ID: 3577663665 Enrollment ID: O20070702000417 |
News Archive
Today's headlines include reports about how the day-after debate about the Congressional Budget Office's updated health law projections played out on Capitol Hill.
Depression is a worldwide problem, with serious consequences for individual health and the economy, and rapid and effective screening tools are thus urgently needed to counteract its increasing prevalence.
High levels of public support for strict measures to control COVID-19 during the first wave of the pandemic did not reflect high levels of public trust in the UK government's honesty, transparency or motives, suggests a new study published in PLOS One.
As the Senate Finance Committee finalizes its health reform proposal, medical-device makers are hoping to convince lawmakers to make one last change, The Wall Street Journal reports. "The Advanced Medical Technology Association, or AdvaMed, the trade group for the larger device manufacturers, wants [Committee Chair Max Baucus of Montana] to reduce $40 billion in fees over the next decade to $15 billion, according to people close to the negotiations. But industry was told that offer is too low.
The US Food and Drug Administration has granted marketing approval to GlaxoSmithKline's new type 2 diabetes drug, branded Tanzeum in the US and Eperzan in Europe, which uses Novozymes' Veltis technology to achieve an extended half-life that means patients are only required to inject their medication once a week.
› Verified 2 days ago
| Entity Name | Providence Wa Anesthesia Services, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669615894 PECOS PAC ID: 9335298884 Enrollment ID: O20090513000135 |
News Archive
Today's headlines include reports about how the day-after debate about the Congressional Budget Office's updated health law projections played out on Capitol Hill.
Depression is a worldwide problem, with serious consequences for individual health and the economy, and rapid and effective screening tools are thus urgently needed to counteract its increasing prevalence.
High levels of public support for strict measures to control COVID-19 during the first wave of the pandemic did not reflect high levels of public trust in the UK government's honesty, transparency or motives, suggests a new study published in PLOS One.
As the Senate Finance Committee finalizes its health reform proposal, medical-device makers are hoping to convince lawmakers to make one last change, The Wall Street Journal reports. "The Advanced Medical Technology Association, or AdvaMed, the trade group for the larger device manufacturers, wants [Committee Chair Max Baucus of Montana] to reduce $40 billion in fees over the next decade to $15 billion, according to people close to the negotiations. But industry was told that offer is too low.
The US Food and Drug Administration has granted marketing approval to GlaxoSmithKline's new type 2 diabetes drug, branded Tanzeum in the US and Eperzan in Europe, which uses Novozymes' Veltis technology to achieve an extended half-life that means patients are only required to inject their medication once a week.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Philip Warren Early, MD 755 Ne Brookcliff Ln, Bainbridge Island, WA 98110-3965 Ph: (206) 842-3385 | Mr Philip Warren Early, MD 755 Ne Brookcliff Ln, Bainbridge Island, WA 98110-3965 Ph: (206) 842-3385 |
News Archive
Today's headlines include reports about how the day-after debate about the Congressional Budget Office's updated health law projections played out on Capitol Hill.
Depression is a worldwide problem, with serious consequences for individual health and the economy, and rapid and effective screening tools are thus urgently needed to counteract its increasing prevalence.
High levels of public support for strict measures to control COVID-19 during the first wave of the pandemic did not reflect high levels of public trust in the UK government's honesty, transparency or motives, suggests a new study published in PLOS One.
As the Senate Finance Committee finalizes its health reform proposal, medical-device makers are hoping to convince lawmakers to make one last change, The Wall Street Journal reports. "The Advanced Medical Technology Association, or AdvaMed, the trade group for the larger device manufacturers, wants [Committee Chair Max Baucus of Montana] to reduce $40 billion in fees over the next decade to $15 billion, according to people close to the negotiations. But industry was told that offer is too low.
The US Food and Drug Administration has granted marketing approval to GlaxoSmithKline's new type 2 diabetes drug, branded Tanzeum in the US and Eperzan in Europe, which uses Novozymes' Veltis technology to achieve an extended half-life that means patients are only required to inject their medication once a week.
› Verified 2 days ago